Selena Chen

Selena Chen

Auto-generated profile, based on publicly available information

Selena Chen

Division of Biological Sciences, University of California, San Diego, La Jolla, CA, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in Frontiers in Pediatrics
Verified
Journal Article
Open access
YLYining Li
Yining Li
YYYuqing Yu
Yuqing Yu
SCSelena Chen
Selena Chen
Ying LiaoYing Liao
Ying Liao
Junbao DuJunbao Du
Junbao Du
Background: The efficacy of corticosteroids and intravenous immunoglobulin (IVIG) in pediatric myocarditis remains controversial. Objectives: The authors performed a meta-analysis to assess the therapeutic efficacy of corticosteroids and IVIG in children with myocarditis. Methods: We retrieved the trials on corticosteroids and IVIG therapy, respectively, in pediatric myocarditis from nine databases up to December 2018. Statistical analysis was performed using Review Manager 5.3. Results: Our analysis included 8 studies and 334 pediatric patients. The data demonstrated that children receiving corticosteroids showed no significant improvement on left ventricular ejection fraction (LVEF) from 1 to 8 month-follow-up (MD = 5.17%, 95% CI = -0.26% to 10.60%, P = 0.06), and no significant improvement in death or heart transplantation incidence at the end of follow-up (OR = 1.33, 95% CI = 0.27-6.70, P = 0.73). However, children receiving IVIG revealed a statistically remarkable increase in LVEF at a follow-up over the course of 6 months to 1 year (MD = 18.91%, 95% CI = 11.74-26.08%, P < 0.00001), and a decrease in death or heart transplantation at the end of follow-up (OR = 0.31, 95% CI = 0.12-0.75, P = 0.01). Further comparisons showed that the mortality and heart transplantation rate of children with myocarditis treated with IVIG were significantly lower than those with corticosteroid therapy (t' = 11.336, P < 0.001). Conclusions: IVIG might be beneficial to improve LVEF and survival for myocarditis in children. However, the present evidence does not support corticosteroids as superior to conventional therapy in children with myocarditis. Further randomized controlled trials with a larger sample size are required.

26 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJing Lin
Jing Lin
ZHZhenhui Han
Zhenhui Han
HLHongxia Li
Hongxia Li
SCSelena Ying Chen
Selena Ying Chen
XLXueying Li
Xueying Li
Hongfang JinHongfang Jin
Hongfang Jin
POTS is a global public-health disease, but predictor for therapeutic response to metoprolol in children with POTS is lacking. This study was designed to investigate predictive value of plasma C-type natriuretic peptide (CNP) in the therapeutic efficacy of metoprolol on postural tachycardia syndrome (POTS) in children. Totally 34 children with POTS and 27 healthy children were included in the study. The head-up test or head-up tilt test was used to check heart rate and blood pressure from supine to upright in subjects. A double antibody (competitive) sandwich immunoluminometric assay was used to detect plasma CNP. Metoprolol was used to treat children with POTS. The difference in plasma concentrations of CNP between responders and non-responders was compared. An ROC curve was used to analyze plasma CNP to predict efficacy of metoprolol on POTS in children. Plasma CNP in children with POTS was significantly higher than that of healthy children [(51.9 ± 31.4) vs. (25.1 ± 19.1) pg/ml, P 32.55 pg/ml yielded a sensitivity of 95.8% and specificity of 70% in predicting therapeutic efficacy of metoprolol on POTS children. Plasma CNP might serve as a useful predictor for the therapeutic efficacy of metoprolol on POTS in children.

1 June 2016 in Scientific Reports
Verified
Journal Article
Open access
HZHeng Zhang
Heng Zhang
YHYaqian Huang
Yaqian Huang
DBDingfang Bu
Dingfang Bu
SCSelena Chen
Selena Chen
CTChaoshu Tang
Chaoshu Tang
Hongfang JinHongfang Jin
Hongfang Jin
The present study was designed to determine whether sulfur dioxide (SO2) could be endogenously produced in adipocyte and served as a novel adipocyte-derived inflammatory inhibitor. SO2 was detected in adipose tissue using high-performance liquid chromatography with fluorescence detection. SO2 synthase aspartate aminotransferase (AAT1 and AAT2) mRNA and protein expressions in adipose tissues were measured. For in vitro study, 3T3-L1 adipocytes were cultured, infected with adenovirus carrying AAT1 gene or lentivirus carrying shRNA to AAT1, and then treated with tumor necrosis factor-α (TNF-α). We found that endogenous SO2/AAT pathway existed in adipose tissues including perivascular, perirenal, epididymal, subcutaneous and brown adipose tissue. AAT1 overexpression significantly increased SO2 production and inhibited TNF-α-induced inflammatory factors, monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) secretion from 3T3-L1 adipocytes. By contrast, AAT1 knockdown decreased SO2 production and exacerbated TNF-α-stimulated MCP-1 and IL-8 secretion. Mechanistically, AAT1 overexpression attenuated TNF-α-induced IκBα phosphorylation and degradation, and nuclear factor-κB (NF-κB) p65 phosphorylation, while AAT1 knockdown aggravated TNF-α-activated NF-κB pathway, which was blocked by SO2. NF-κB inhibitors, PDTC or Bay 11-7082, abolished excessive p65 phosphorylation and adipocyte inflammation induced by AAT1 knockdown. This is the first report to suggest that endogenous SO2 is a novel adipocyte-derived inflammatory inhibitor.

1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JLJia Liu
Jia Liu
YHYaqian Huang
Yaqian Huang
SCSelena Chen
Selena Chen
CTChaoshu Tang
Chaoshu Tang
Hongfang JinHongfang Jin
Hongfang Jin
Junbao DuJunbao Du
Junbao Du
Sulfur dioxide (SO2), an emerging gasotransmitter, was discovered to be endogenously generated in the cardiovascular system. Recently, the physiological effects of endogenous SO2 were confirmed. Vascular structural remodeling (VSR), an important pathological change in many cardiovascular diseases, plays a crucial role in the pathogenesis of the diseases. Here, the authors reviewed the research progress of endogenous SO2 in regulating VSR by searching the relevant data from PubMed and Medline. In spontaneously hypertensive rats (SHRs) and pulmonary hypertensive rats, SO2/aspartate aminotransferase (AAT) pathway was significantly altered. SO2 inhibited vascular smooth muscle cell (VSMC) proliferation, promoted apoptosis, inhibited the synthesis of extracellular collagen but promoted its degradation, and enhanced antioxidative capacity, thereby playing a significant role in attenuating VSR. However, the detailed mechanisms needed to be further explored. Further studies in this field would be important for the better understanding of the pathogenesis of systemic hypertension and pulmonary hypertension. Also, clinical trials are needed to demonstrate if SO2 would be a potential therapeutic target in cardiovascular diseases.

5 April 2018 in Chinese Medical Journal
Verified
Journal Article
Open access
QZQing-You Zhang
Qing-You Zhang
Hongfang JinHongfang Jin
Hongfang Jin
SCSelena Chen
Selena Chen
QCQing-Hua Chen
Qing-Hua Chen
CTChao-Shu Tang
Chao-Shu Tang
YHYaqian Huang
Yaqian Huang
Objective:Hydrogen sulfide (H2S), a gaseous signal molecule, plays a crucial role in many pathophysiologic processes in the cardiovascular system. Autophagy has been shown to participate in the occurrence of many cardiac diseases. Increasing evidences indicated that H2S regulates myocardial structur

3 October 2016 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
WYWen Yu
Wen Yu
DLDie Liu
Die Liu
CLChen Liang
Chen Liang
TOTodd Ochs
Todd Ochs
SCStella Chen
Stella Chen
Hongfang JinHongfang Jin
Hongfang Jin
Background: We aimed to explore the role of endogenous sulfur dioxide ( SO 2 ) in pulmonary vascular collagen remodeling induced by monocrotaline and its mechanisms. Methods and Results: A rat model of monocrotaline‐induced pulmonary vascular collagen remodeling was developed and administered with l ‐aspartate‐β‐hydroxamate or SO 2 donor. The morphology of small pulmonary arteries and collagen metabolism were examined. Cultured pulmonary arterial fibroblasts stimulated by transforming growth factor β1 ( TGF ‐β1) were used to explore the mechanism. The results showed that in monocrotaline‐treated rats, mean pulmonary artery pressure increased markedly, small pulmonary arterial remodeling developed, and collagen deposition in lung tissue and pulmonary arteries increased significantly in association with elevated SO 2 content, aspartate aminotransferase (AAT) activity, and expression of AAT1 compared with control rats. Interestingly, l ‐aspartate‐β‐hydroxamate, an inhibitor of SO 2 generation, further aggravated pulmonary vascular collagen remodeling in monocrotaline‐treated rats, and inhibition of SO 2 in pulmonary artery smooth muscle cells activated collagen accumulation in pulmonary arterial fibroblasts. SO 2 donor, however, alleviated pulmonary vascular collagen remodeling with inhibited collagen synthesis, augmented collagen degradation, and decreased TGF ‐β1 expression of pulmonary arteries. Mechanistically, overexpression of AAT1, a key enzyme of SO 2 production, prevented the activation of the TGF ‐β/type I TGF ‐β receptor/Smad2/3 signaling pathway and abnormal collagen synthesis in pulmonary arterial fibroblasts. In contrast, knockdown of AAT1 exacerbated Smad2/3 phosphorylation and deposition of collagen types I and III in TGF ‐β1–treated pulmonary arterial fibroblasts. Conclusions: Endogenous SO 2 plays a protective role in pulmonary artery collagen accumulation induced by monocrotaline via inhibition of the TGF ‐β/type I TGF ‐β receptor/Smad2/3 pathway.